Following the acquisition, Bergstrom Nutrition will be part of Balchem’s Human Nutrition and Health business segment and integrated into the Minerals & Nutrients business unit.
Balchem Corporation (New Hampton, NY) has announced the acquisition of leading methylsulfonylmethane (MSM) manufacturer Bergstrom Nutrition (Vancouver, WA). Bergstrom’s MSM brand OptiMSM carries a GRAS (generally recognized as safe) designation. Following the acquisition, Bergstrom Nutrition will be part of Balchem’s Human Nutrition and Health business segment and integrated into the Minerals & Nutrients business unit.
“We are excited to welcome Bergstrom Nutrition to Balchem. As the MSM market leader, Bergstrom Nutrition has excelled in advancing the science and presence of MSM globally,” said Ted Harris, chairman, CEO and president of Balchem, in a press release. “The addition of OptiMSM to our portfolio provides a synergistic scientific advantage in Balchem’s key strategic therapeutic focus areas such as longevity and performance and is a strong fit with Balchem’s specialty, science-backed mineral products. We look forward to expanding marketplace opportunities together.”
“We are very pleased to join such a high quality, scientifically driven organization as Balchem,” offered Adrian Polliack, Bergstrom Nutrition’s president and CEO. “OptiMSM aligns well with Balchem’s already robust portfolio and complements their strategic health benefit platforms. Joining Balchem allows for accelerated growth and market reach and we look forward to working together with the Balchem team.”
New study shows that vitamin K2 as MK-7 may have neuroprotective qualities
May 17th 2024Researchers examined the effects of MK-7 and menaquinone-4 (MK-4) on neuroblastoma cells to understand how different forms of vitamin K2 impact the expression of genes involved in neurodegeneration and neuroinflammation.
Judge in CRN’s complaint against NY denies the State’s motion to dismiss
May 14th 2024New York State's motion to dismiss CRN's lawsuit against the law banning the sale of weight management and muscle-building supplements to minors has been partially denied, allowing CRN to proceed with its First Amendment Claim.